Form 4: Veracyte VP, Chief Accounting Officer, Jonathan Wygant, Reports Stock Transactions

Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., reported the disposal of shares to cover tax obligations and a sale of shares on December 2nd and 3rd, 2024.

Summary

• Jonathan Wygant, the VP and Chief Accounting Officer of Veracyte, Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
• On December 2, 2024, 1,087 shares were disposed of to cover tax obligations related to the vesting of restricted stock units, at a price of $44.12 per share.
• These shares were not sold by the reporting person but were withheld to satisfy tax obligations.
• On December 3, 2024, 956 shares were sold at a price of $43.3603 per share.
• Following these transactions, Wygant beneficially owns 40,270 shares of Veracyte stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by an executive, which is neither positive nor negative for the company's overall outlook.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice for publicly traded companies. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transactions are typical for executives who receive stock-based compensation and need to cover tax obligations upon vesting.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and do not indicate a significant change in the company's fundamentals.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transactions, Veracyte, VCYT, Insider Trading, Restricted Stock Units, Tax Withholding